Maintenance immunotherapy in advanced urothelial cancer
Advanced urothelial carcinoma usually responds to platinum-based chemotherapy (CT), although overall survival (OS) and progression-free survival are typically short. Immunotherapy is a promising treatment strategy, but the first-line benefits in platinum-eligible patients are limited, and its combin...
Shranjeno v:
| Principais autores: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Permanyer
2022-07-01
|
| Serija: | Gaceta Mexicana de Oncología |
| Teme: | |
| Online dostop: | https://www.gamo-smeo.com/frame_esp.php?id=323 |
| Oznake: |
Brez oznak, prvi označite!
|